secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001140361-25-022212
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDSB stockholders approve amendment increasing equity plan shares by 3.14M
--------------------------------------------------------------------------

- Stephen Glover and Gregory Freitag elected as Class A directors at annual meeting.
- Amendment to 2014 Equity Incentive Plan approved, adding 3,144,049 shares for total 9,709,584.
- Ratification of KPMG US LLP as auditor for FY2025 passed with 25.6M votes for.
- Advisory vote on named executive officer compensation approved, with 8.98M votes for.
- About 65.97% of outstanding shares (30.1M) voted, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125022212/0001140361-25-022212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125022212/ef20050526_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-022212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer